GENE ONLINE|News &
Opinion
Blog

CTX001
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
GeneOnline’s Top 10 Headlines of the Year
2020-12-30
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
CRISPR, Vertex’s Gene Editing Based Therapy, CTX001 Prospers in Hemoglobinopathy Trials
2020-06-18
LATEST
Biotech Sector Updates: Reports Cover Research Advances and Industry Events
2025-05-14
GSK Adds Efimosfermin to Hepatology Portfolio, Citing Novel Mechanism of Action for Liver Disease Treatment
2025-05-14
New Generic Drug Impacts Oncology and Community Pharmacists.
2025-05-14
Novo Nordisk and Septerna Partner to Develop Oral Obesity Medications
2025-05-14
Ixchiq Vaccine Adverse Event Investigations Focus on Elderly Recipients
2025-05-14
Liver Disease Treatment Investment Resurges Amid Growing Unmet Needs
2025-05-14
Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top